TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T53024	Somatostatin receptor type 2	B15GVZ	Methyl 3-[3-[3-[3-[3-[acetyl(benzyl)amino]propanoyl-[2-(1H-indol-3-yl)ethyl]amino]propanoyl-(4-aminobutyl)amino]propanoyl-[(2R)-2-hydroxypropyl]amino]propanoyl-benzylamino]propanoate	Investigative	90665463	C49H67N7O8	882.1	C[C@H](CN(CCC(=O)N(CCC(=O)OC)CC1=CC=CC=C1)C(=O)CCN(CCCCN)C(=O)CCN(CCC2=CNC3=CC=CC=C32)C(=O)CCN(CC4=CC=CC=C4)C(=O)C)O	Ki = 55000 nM	Poor binder
T53024	Somatostatin receptor type 2	B1HUM9	(1R,3R)-3-(4-(5-Fluoropyridin-2-yl)-1H-imidazol-2-yl)-1-(1-ethyl-pyrazol-4-yl)-1-(3-methyl-1,3,4-oxadiazol-3H-2-one-5-yl)-2,3,4,9-tetrahydro-1H-ss-carboline	Investigative	122179477	C27H24FN9O2	525.5	CCN1C=C(C=N1)[C@@]2(C3=C(C[C@@H](N2)C4=NC=C(N4)C5=NC=C(C=C5)F)C6=CC=CC=C6N3)C7=NN(C(=O)O7)C	IC50 ~ 100000 nM	Poor binder
T53024	Somatostatin receptor type 2	B21MXC	1-(4-Aminobutyl)-8-benzyl-12-[(2R)-2-hydroxypropyl]-4-[2-(1H-indol-3-yl)ethyl]-1,4,8,12-tetrazacyclopentadecane-2,5,9,13-tetrone	Investigative	90665458	C35H48N6O5	632.8	C[C@H](CN1CCC(=O)N(CCC(=O)N(CC(=O)N(CCC1=O)CCCCN)CCC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)O	Ki = 176000 nM	Poor binder
T53024	Somatostatin receptor type 2	B41GPO	Methyl 3-[3-[3-[[2-[3-[acetyl(benzyl)amino]propanoyl-[2-(1H-indol-3-yl)ethyl]amino]acetyl]-(4-aminobutyl)amino]propanoyl-[(2R)-2-hydroxypropyl]amino]propanoyl-benzylamino]propanoate	Investigative	90665462	C48H65N7O8	868.1	C[C@H](CN(CCC(=O)N(CCC(=O)OC)CC1=CC=CC=C1)C(=O)CCN(CCCCN)C(=O)CN(CCC2=CNC3=CC=CC=C32)C(=O)CCN(CC4=CC=CC=C4)C(=O)C)O	Ki = 110000 nM	Poor binder
T53024	Somatostatin receptor type 2	B9YQD8	3-[3-(2-Pyridinylamino)propyl]-1-[3-[(2-pyridinyl)(4-bromobenzyl)amino]propyl]thiourea	Investigative	10815650	C24H29BrN6S	513.5	C1=CC=NC(=C1)NCCCNC(=S)NCCCN(CC2=CC=C(C=C2)Br)C3=CC=CC=N3	Ki = 114000 nM	Poor binder
T53024	Somatostatin receptor type 2	BM6B4N	3-[2-(2-Pyridinyl)ethyl]-1-[3-[(5-bromo-2-pyridinyl)(3,4-dichlorobenzyl)amino]propyl]thiourea	Investigative	10816544	C23H24BrCl2N5S	553.3	C1=CC=NC(=C1)CCNC(=S)NCCCN(CC2=CC(=C(C=C2)Cl)Cl)C3=NC=C(C=C3)Br	Ki = 74000 nM	Poor binder
T53024	Somatostatin receptor type 2	BZW6E8	1-(4-Aminobutyl)-9-benzyl-13-[(2R)-2-hydroxypropyl]-5-[2-(1H-indol-3-yl)ethyl]-1,5,9,13-tetrazacyclohexadecane-2,6,10,14-tetrone	Investigative	90665459	C36H50N6O5	646.8	C[C@H](CN1CCC(=O)N(CCC(=O)N(CCC(=O)N(CCC1=O)CCCCN)CCC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)O	Ki = 198000 nM	Poor binder